Published on Linkedin on November 8th, 2025 Reading Qatar’s latest precision medicine and national strategy reports as my flight approached Doha, I found myself genuinely impressed and, as a veteran of biomedical strategy, more than… Qatar’s Precision Medicine Leap: From Vision to Innovation Economy
Published on Linkedin on October 12, 2025 I just spent three intense days at BioSpain 2025 (https://www.asebio.com/en/news-events/news/biospain-2025-closes-record-attendance-and-passes-baton-bilbao-2026-host-city), participating in a most intense (!) partnering marathon, and also had the privilege of participating in two roundtables.… Reflecting on Barcelona’s Ecosystem: Twenty-Odd Years of Convergence
At 35, Sarah suffered a heart attack that a €30 genetic test could have prevented. Her story isn’t unusual, it’s a mirror of how health systems worldwide confuse “standard care” with equity. Sarah, a 34-year-old… Precision Medicine Isn’t Elitist: It’s the Only Equitable Option
The European Union proclaimed its 1+ Million Genomes initiative in April 2018, with 26 Member States committing to create federated genomic infrastructure. Six years later, we can’t even determine how many genomes Europe has actually… Europe’s Genomic “Ambition” (?): The Transparency Test
“70% of clinical decisions depend on diagnostics.” You’ve seen this statistic, but it hides an important detail: timing. The acuity gradient: Lab testing occurs in 98% of inpatient encounters, 56% in emergency departments, but only… The Diagnostic Timing Trap
Published on Linkedin on August 3rd, 2025 While everyone chases longevity drugs, the real fountain of youth sits in your liver In the ever-expanding dialogue around longevity in a medical setting, we hear a lot… The Liver – Longevity Connection: Why Precision Liver Medicine Deserves a Seat at the Longevity Table
published on Linkedin on 20 July 2025. Every week, my LinkedIn feed is filled with billion-dollar AI alliances, breakthrough biomarker announcements, and government blueprints for “future healthcare.” Locally and globally, the numbers are extraordinary: the… If Precision Medicine Is the Future, Why Are We Neglecting Its Foundation?
Published on linkedin on June 17th 1. Not enough evidence! When we first embarked on developing Hepatopredict, our idea was very clear: create a biomarker-based test that could reliably inform clinical decisions about liver transplantation… From Promising to Proven: Lessons from the Validation Trenches of Biomarker Development
Published on MedEdgeMEA on May 31th Introduction: A New Frontier for Liver Transplantation Precision medicine has transformed fields like oncology and cardiology, but liver transplantation has been left behind. Despite being a domain where decisions… Liver Transplantation Enters the Era of Precision Diagnostics
By José Pereira Leal To the memory of Gordon Hisashi Sato (1927–2017), Scientist extraordinaire who inspired me, and many others, to imagine new rivers through the desert. Like many of his generation who witnessed the… Salty rivers into the desert: How Saltwater Canals Could Transform UAE Deserts into Climate-Resilient Food Systems